Abtrace Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 58

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 10

Abtrace General Information

Description

Developer of proactive patient monitoring and clinical recall software designed to automate chronic disease tracking and healthcare outreach. The company's platform integrates directly with primary care electronic health record systems to read patient records, identifies individuals due or overdue for medical tests, routine reviews, and vaccinations, automates patient recall communications with self-booking links, manages high-risk drug monitoring and repeat prescription checks, supports clinical coding corrections, and tracks regulatory quality framework targets, enabling general practices, primary care networks, and healthcare providers to eliminate manual administrative tracking, maintain clinical compliance, and deliver timely preventive care to patients.

Contact Information

Website
www.abtrace.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8 Hermitage Street
  • Paddington
  • London W2 1BE
  • England, United Kingdom
+44 020
Primary Industry
Decision/Risk Analysis
Other Industries
Medical Records Systems
Corporate Office
  • 8 Hermitage Street
  • Paddington
  • London W2 1BE
  • England, United Kingdom
+44 020

Abtrace Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abtrace Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
10. Accelerator/Incubator 01-Feb-2025 Completed Generating Revenue
9. Later Stage VC 16-Nov-2023 Completed Generating Revenue
8. Accelerator/Incubator 01-Jul-2023 Completed Generating Revenue
7. Grant 01-Oct-2022 Completed Generating Revenue
6. Accelerator/Incubator 31-Mar-2022 Completed Generating Revenue
5. Accelerator/Incubator 29-Mar-2022 Completed Generating Revenue
4. Seed Round 25-Aug-2021 Completed Generating Revenue
3. Grant 01-Nov-2020 $514K $2.28M Completed Generating Revenue
2. Accelerator/Incubator 23-Nov-2018 $2.28M $2.28M Completed Generating Revenue
To view Abtrace’s complete valuation and funding history, request access »

Abtrace Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed Preferred Plus 2
Seed Preferred Plus 1
Preference 366,666 $0.000001 $3.67 $3.67 1x $3.67 8.13%
To view Abtrace’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Abtrace Patents

Abtrace Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202206976-D0 Fluid delivery system Active 12-May-2022
GB-2618605-A Fluid delivery system Active 12-May-2022
GB-2618605-B Fluid delivery system Active 12-May-2022
WO-2023218200-A1 Fluid delivery system Inactive 12-May-2022 A61M5/142

Abtrace Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abtrace Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tech Nation Group Accelerator/Incubator
Grow London Accelerator/Incubator
Triple Point Asset Manager Minority
DigitalHealth.London Accelerator Accelerator/Incubator
The NHS Innovation Accelerator Accelerator/Incubator
You’re viewing 5 of 10 investors. Get the full list »

Abtrace FAQs

  • When was Abtrace founded?

    Abtrace was founded in 2018.

  • Where is Abtrace headquartered?

    Abtrace is headquartered in London, United Kingdom.

  • What is the size of Abtrace?

    Abtrace has 58 total employees.

  • What industry is Abtrace in?

    Abtrace’s primary industry is Decision/Risk Analysis.

  • Is Abtrace a private or public company?

    Abtrace is a Private company.

  • What is Abtrace’s current revenue?

    The current revenue for Abtrace is .

  • How much funding has Abtrace raised over time?

    Abtrace has raised $11.5M.

  • Who are Abtrace’s investors?

    Tech Nation Group, Grow London, Triple Point, DigitalHealth.London Accelerator, and The NHS Innovation Accelerator are 5 of 10 investors who have invested in Abtrace.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process